Trials / Completed
CompletedNCT04184999
Effect of Intraoperative Dexamethasone on Post-op Dry Eye
Evaluation of Intraoperative Use of Dexycu on the Signs and Symptoms of Dry Eye
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- SR Cornea Consultants · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
To compare the signs and symptoms of dry eye after cataract surgery between subjects randomized to receive intraoperative dexamethasone in addition to the use of a standard topical post-op treatment regimen.
Detailed description
Forty patients requiring cataract surgery will be randomized to treatment of post-operative inflammation with a single intraoperative dexamethasone injection plus a standard course of topical ophthalmic corticosteroid drops or the standard treatment alone. Dry eye testing will be administered at baseline, 1 week and 3 weeks following surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | dexamethasone intraocular suspension, 9% | single dose intracameral corticosteroid |
| DRUG | Prednisolone Acetate 1% Oph Susp | topical ophthalmic steroid drop |
Timeline
- Start date
- 2019-08-10
- Primary completion
- 2019-12-01
- Completion
- 2019-12-01
- First posted
- 2019-12-04
- Last updated
- 2023-11-22
- Results posted
- 2021-01-29
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04184999. Inclusion in this directory is not an endorsement.